Synthesis and in Vitro Cytotoxicity Profile of the R-Enantiomer of 3,4-Dihydroxymethamphetamine (R-(-)-HHMA): Comparison with Related Catecholamines

被引:7
|
作者
Felim, Anne [2 ]
Herrera, Guadalupe [1 ]
Neudoerffer, Anne [2 ]
Blanco, Manuel [1 ]
O'Connor, Jose-Enrique [1 ]
Largeron, Martine [2 ]
机构
[1] Ctr Invest Principe Felipe, Unidad Mixta Invest CIPF UVEG, Lab Cit, Valencia 46012, Spain
[2] Univ Paris 05, UMR CNRS 8638, Fac Sci Pharmaceut & Biol, F-75270 Paris 06, France
关键词
NEUROTOXIC THIOETHER METABOLITES; N-ALKYL DERIVATIVES; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; RAT-BRAIN; ESCHERICHIA-COLI; MAIN METABOLITES; CELL-DEATH; ECSTASY; TOXICITY; DOPAMINE;
D O I
10.1021/tx9003374
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
(+/-)-3,4-Methylenedioxymethamphetamine (MDMA, also known as "ecstasy") is a chiral drug that is essentially metabolized in humans through O-demethylenation into 3,4-dihydroxymethamphetamine (HHMA). There has recently been a resurgence of interest in the possibility that MDMA metabolities, especially 5-(N-acetylcysten-S-yl)-N-methyl-alpha-methyldopamine (designated its 5-NAC-HHMA), might play it role in MDMA neurotoxicity. However, the chirality of MDMA was not considered in previously reported ill vivo Studies because HHMA, the precursor of the 5-NAC-HHMA metabolite, was used the racemate. Since the stereochemistry of this chiral drug needs to be considered, the first total Synthesis of R-(-)-HHMA is reported. Using L-DOPA as the chiral source, the preparation of R-(-)-HHMA is achieved through seven steps. in 30% overall yield and 99.5% enantiomeric excess. The cytotoxicity of R-(-)-HHMA and related catecholamines has been further determined by flow cytometric analysis of propidium iodide uptake in human dopaminergic neuroblastoma SH-SY5Y cells and by in Escherichia coli plate assay, specific for the detection of oxidative toxicity. The good correlation between the toxicities observed in bath systems suggests that. SH-SY5Y cells are sensitive to oxidative toxicity and that cell death (necrosis) would be mediated by reactive oxygen species mainly generated from redox active quinonoid centers. In contrast, apoptosis was detected for 3,4-dimethoxymethamphetamine (MMMA), the synthetic precursor of HHMA possessing it protected catechol group. MMMA was not toxic in the bacterial assay, indicating that its toxicity is not related to increased oxidative stress. Finally, we can conclude that there is a need to distinguish the toxicity ascribed to MDMA itself, also bearing it protected catechol moiety, from that depending oil MDMA biotransformation leading to catechol metabolites Such as HHMA and the thioether conjugates.
引用
收藏
页码:211 / 219
页数:9
相关论文
共 20 条
  • [1] Induction of glutathione synthesis and conjugation by 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-dihydroxymethamphetamine (HHMA) in human and rat liver cells, including the protective role of some antioxidants
    Antolino-Lobo, Irene
    Meulenbelt, Jan
    Molendijk, Jeffrey
    Nijmeijer, Sandra M.
    Scherpenisse, Peter
    van den Berg, Martin
    van Duursen, Majorie B. M.
    TOXICOLOGY, 2011, 289 (2-3) : 175 - 184
  • [2] SYNTHESIS OF ENANTIOMERICALLY PURE (S)-(+)-3-HYDROXYTETRAHYDROFURAN AND ITS R-ENANTIOMER FROM MALIC OR TARTARIC ACID
    TANDON, VK
    VANLEUSEN, AM
    WYNBERG, H
    JOURNAL OF ORGANIC CHEMISTRY, 1983, 48 (16): : 2767 - 2769
  • [3] SYNTHESIS OF THE R-ENANTIOMER AND S-ENANTIOMER OF 1,2,3,4-TETRAHYDRO-6,7-DIHYDROXY-1-METHYLISOQUINOLINE-1-CARBOXYLIC ACID
    DOSTERT, P
    VARASI, M
    DELLATORRE, A
    MONTI, C
    RIZZO, V
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1992, 27 (01) : 57 - 59
  • [4] Synthesis and Enantiopreferential DNA-Binding Profile of Late 3d Transition Metal R- and S-Enantiomeric Complexes Derived from N,N-Bis-(1-benzyl-2-ethoxyethane): Validation of R-Enantiomer of Copper(II) Complex as a Human Topoisomerase II Inhibitor
    Arjmand, Farukh
    Sharma, Girish Chandra
    Muddassir, Mohd
    Tabassum, Sartaj
    CHIRALITY, 2011, 23 (07) : 557 - 567
  • [5] R-Substituent vs. exocyclic oxygen: influence on synthesis and crystal packing of R-[1,2,5]oxadiazolo[3,4-c]cinnoline mono- and dioxides
    Zelenov, Victor P.
    Fedyanin, Ivan V.
    Samigullina, Aida I.
    Larin, Alexandr A.
    Sheremetev, Aleksei B.
    CRYSTENGCOMM, 2025, 27 (03) : 372 - 385
  • [6] Preparation and pharmacological characterization of the enantiomers of the anticancer agent R / S- N-3-cyanophenyl- N '-(6-tert-butoxycarbonylamino-3,4-dihydro-2 , 2-dimethyl-2H-1-benzopyran-4-yl)urea: Identification of the R-enantiomer as the active eutomer
    Schnekenburger, Michael
    Goffin, Eric
    Schoumacher, Matthieu
    Tumanov, Nikolay
    Mouithys-Mickalad, Ange
    de Tullio, Pascal
    Wouters, Johan
    Lebrun, Philippe
    Diederich, Marc
    Pirotte, Bernard
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2025, 13
  • [7] Preparation, DNA binding, and in vitro cytotoxicity of a pair of enantiomeric platinum(II) complexes, [(R)- and (S)-3-aminohexahydroazepine]dichloro-platinum(II). Crystal structure of the S enantiomer
    Fenton, RR
    Easdale, WJ
    Er, HM
    OMara, SM
    McKeage, MJ
    Russell, PJ
    Hambley, TW
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (07) : 1090 - 1098
  • [8] Design and synthesis of enantiomeric (R)- and (S)-copper(II) and diorganotin(IV)-based antitumor agents: Their in vitro DNA binding profile, cleavage efficiency and cytotoxicity studies
    Arjmand, Farukh
    Muddassir, Mohd.
    Yousuf, Imtiyaz
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2014, 136 : 62 - 71
  • [9] CONVENIENT ACCESS TO 2 ENANTIOMERIC OXIRANE SYNTHONS BEARING A QUATERNARY GEM-DIMETHYL CARBON CENTER - SYNTHESIS OF 3S-(+) AND 3R-(-)-2,2-DIMETHYL-3,4-OXO-1-BUTANOL FROM R-(-)-PANTOLACTONE
    LAVALLEE, P
    RUEL, R
    GRENIER, L
    BISSONNETTE, M
    TETRAHEDRON LETTERS, 1986, 27 (06) : 679 - 682
  • [10] Design, Synthesis, and Biological Evaluation of (3R)-1,2,3,4-Tetrahydro-7-hydroxy-N-[(1S)-1-[[(3R,4R)-4-(3-hydroniphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl]-3-isoquinolinecarboxamide (JDTic) Analogues: In Vitro Pharmacology and ADME Profile
    Kormos, Chad M.
    Gichinga, Moses G.
    Maitra, Rangan
    Runyon, Scott P.
    Thomas, James B.
    Brieaddy, Lawrence E.
    Mascarella, S. Wayne
    Navarro, Hernan A.
    Carroll, F. Ivy
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (17) : 7367 - 7381